These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

741 related items for PubMed ID: 19484663

  • 1. Mechanisms of sublingual immunotherapy.
    Scadding G, Durham S.
    J Asthma; 2009 May; 46(4):322-34. PubMed ID: 19484663
    [Abstract] [Full Text] [Related]

  • 2. Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy.
    Pipet A, Botturi K, Pinot D, Vervloet D, Magnan A.
    Respir Med; 2009 Jun; 103(6):800-12. PubMed ID: 19216064
    [Abstract] [Full Text] [Related]

  • 3. Multiallergen immunotherapy for allergic rhinitis and asthma.
    Nelson HS.
    J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
    [Abstract] [Full Text] [Related]

  • 4. Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma.
    Bahceciler NN, Cobanoglu N.
    Immunotherapy; 2011 Jun; 3(6):747-56. PubMed ID: 21668312
    [Abstract] [Full Text] [Related]

  • 5. [Vaccination with allergens in children].
    Demoly P, Dhivert-Donnadieu H, Bousquet J.
    Allerg Immunol (Paris); 2000 Dec; 32(10):397-401. PubMed ID: 11209473
    [Abstract] [Full Text] [Related]

  • 6. Sublingual immunotherapy.
    Esch RE.
    Curr Opin Otolaryngol Head Neck Surg; 2008 Jun; 16(3):260-4. PubMed ID: 18475082
    [Abstract] [Full Text] [Related]

  • 7. [The value and possibilities of immunotherapy in the treatment of allergic rhinitis].
    Pfaar O, Hörmann K, Klimek L.
    MMW Fortschr Med; 2006 Feb 02; 148(5):28-32. PubMed ID: 16518935
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Specific allergy immunotherapy for allergic rhinitis: subcutaneous and sublingual.
    Cox L, Wallace D.
    Immunol Allergy Clin North Am; 2011 Aug 02; 31(3):561-99. PubMed ID: 21737043
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the long-term efficacy of subcutaneous and sublingual immunotherapies in perennial rhinitis.
    Tahamiler R, Saritzali G, Canakcioglu S, Ozcora E, Dirican A.
    ORL J Otorhinolaryngol Relat Spec; 2008 Aug 02; 70(3):144-50. PubMed ID: 18391573
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Immunological mechanisms of sublingual immunotherapy.
    Akdis CA, Barlan IB, Bahceciler N, Akdis M.
    Allergy; 2006 Aug 02; 61 Suppl 81():11-4. PubMed ID: 16792600
    [Abstract] [Full Text] [Related]

  • 13. How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement.
    Bousquet J, Schünemann HJ, Bousquet PJ, Bachert C, Canonica GW, Casale TB, Demoly P, Durham S, Carlsen KH, Malling HJ, Passalacqua G, Simons FE, Anto J, Baena-Cagnani CE, Bergmann KC, Bieber T, Briggs AH, Brozek J, Calderon MA, Dahl R, Devillier P, Gerth van Wijk R, Howarth P, Larenas D, Papadopoulos NG, Schmid-Grendelmeier P, Zuberbier T.
    Allergy; 2011 Jun 02; 66(6):765-74. PubMed ID: 21496059
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis.
    Tahamiler R, Saritzali G, Canakcioglu S.
    Laryngoscope; 2007 Jun 02; 117(6):965-9. PubMed ID: 17545861
    [Abstract] [Full Text] [Related]

  • 16. Sublingual immunotherapy for children: Are we there yet? Defining its role in clinical practice.
    Campbell DE.
    Paediatr Respir Rev; 2009 Jun 02; 10(2):69-74; quiz 74. PubMed ID: 19410205
    [Abstract] [Full Text] [Related]

  • 17. Recent progress in allergen immunotherapy.
    Nouri-Aria KT.
    Iran J Immunol; 2008 Mar 02; 5(1):1-24. PubMed ID: 18319521
    [Abstract] [Full Text] [Related]

  • 18. Monoid sublingual immunotherapy.
    Palma-Carlos AG, Santos AS, Branco-Ferreira M, Pregal AL, Palma-Carlos ML.
    Eur Ann Allergy Clin Immunol; 2006 Mar 02; 38(3):87-9. PubMed ID: 16752693
    [Abstract] [Full Text] [Related]

  • 19. Sublingual immunotherapy is not always a safe alternative to subcutaneous immunotherapy.
    Cochard MM, Eigenmann PA.
    J Allergy Clin Immunol; 2009 Aug 02; 124(2):378-9. PubMed ID: 19541352
    [No Abstract] [Full Text] [Related]

  • 20. New visions in specific immunotherapy in children: an iPAC summary and future trends.
    Halken S, Lau S, Valovirta E.
    Pediatr Allergy Immunol; 2008 Aug 02; 19 Suppl 19():60-70. PubMed ID: 18665964
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.